TCL Archive Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials By Cancer History Project March 25, 2011
TCL Archive XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study By Cancer History Project March 25, 2011
TCL Archive Study Suggests Biomarker For Resistance to Tamoxifen By Cancer History Project March 25, 2011
TCL Archive McCormick President-Elect of AACR; Garber To Start Term As President By Cancer History Project March 25, 2011
TCL Archive BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma By Cancer History Project March 25, 2011
TCL Archive Radiation, Tamoxifen After Surgery Reduce Breast Cancer Occurrence By Cancer History Project March 25, 2011
TCL Archive Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint By Cancer History Project March 25, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
